Novocure and Stanford School of Medicine to Establish Tumor Treating Fields Research Program

Novocure (NASDAQ: NVCR) today announced it has entered into an agreement with Stanford University to establish the Stanford School of Medicine Tumor Treating Fields (TTFields) Research Program.